The Impact of Non-Invasive Ventilation on Sleep Quality in COPD Patients.

BACKGROUND

Non-invasive ventilation (NIV) has been shown to be the most appropriate therapy for COPD patients with chronic respiratory failure. While physiological parameters and long-term outcome frequently serve as primary outcomes, very few studies have primarily addressed the impact of NIV initiation on sleep quality in COPD.

METHODS

This single-center prospective cohort study comprised NIV-naïve patients with COPD. All patients underwent polysomnographic evaluation both at baseline and at 3 months follow-up, accompanied by the assessment of health-related quality of life (HRQL) using the Severe Respiratory Insufficiency Questionnaire (SRI) and the Epworth Sleepiness Scale (ESS). A subgroup evaluation was performed to address the impact of comorbid obstructive sleep apnea syndrome (OSAS).

RESULTS

Forty-six patients were enrolled and twenty-five patients completed the follow-up period (66.7 ± 7.4 years). NIV resulted in an increase in slow-wave sleep (+2% (-3.5/7.5), = 0.465) and rapid eye movement sleep (+2.2% (-1.0/5.4), = 0.174), although no statistical significance could be detected. ESS (-1.7(-3.6/0.1), = 0.066) also showed a positive trend. Significant improvements in the Respiratory Disturbance Index (RDI) (-12.6(-23.7/-1.5), = 0.027), lung function parameters, transcutaneous PCO and the SRI summary scale (4.5(0.9/8), = 0.016) were observed.

CONCLUSION

NIV therapy does not decrease sleep quality and is even capable of improving HRQL, transcutaneous PaCO, daytime sleepiness and RDI, and the latter especially holds true for patients with comorbid OSAS.